Mass General, Emerson jointly form new cardiovascular center

TriMed Staff | | Health Imaging | Oncology Imaging
The Massachusetts General Hospital (MGH) in Boston and Emerson Hospital in Concord, Mass., have partnered to develop the MGH-Emerson Hospital Cardiovascular Center, to be based at Emerson’s Center of Specialty Care in Concord.

The Cardiovascular Center will offer patients access to physicians from the MGH Heart Center while continuing to grow the two institutions’ existing collaborations in radiation oncology through the MGH Cancer Center and pediatrics and neonatology through the MassGeneral Hospital for Children, the Lincoln Journal reported.

Initially, the MGH-Emerson Cardiovascular Center will be comprised of three clinics staffed by physicians and nurse practitioners from the MGH Heart Center. Specialists in the areas of electrophysiology, women’s heart health and advanced heart failure will provide consultation and treatment and will work with Emerson’s physicians and existing specialty programs to provide patients the best in cardiovascular care.
The MGH-Emerson Hospital Cardiovascular Center is expected to open in late 2008.

TriMed Staff

Related Content

MRI-first approach could allow many to safely forego prostate biopsy
MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.